Aspira (NASDAQ: AWHL) director boosts stake and updates large warrant holdings
Rhea-AI Filing Summary
Aspira Women's Health director Fraser John D filed an amended Form 4 to correct the number of shares indirectly held through Seamark Capital and the presentation of his warrant holdings as of September 17, 2025. He bought 16,389 shares of common stock at $0.45 per share and acquired a warrant for 12,292 underlying shares with a $0.75 exercise price. Following these transactions, he directly owns 566,393 common shares and holds 287,769 shares indirectly via Seamark Capital. He also holds warrants covering 900,633 shares at a $0.35 exercise price expiring in 2031 and 68,627 shares at a $2.25 exercise price expiring in 2027, plus the new warrant for 12,292 shares expiring in 2030.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 16,389 shares
Net Buy
5 txns
Insider
Fraser John D
Role
Director
Bought
28,681 shs ($7K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Warrant (Right to Buy) | 12,292 | $0.00 | $0.00 |
| Purchase | Common Stock | 16,389 | $0.45 | $7K |
| holding | Warrant (Right to Buy) | -- | -- | -- |
| holding | Warrant (Right to Buy) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Warrant (Right to Buy) — 981,552 shares (Direct);
Common Stock — 566,393 shares (Direct);
Common Stock — 287,769 shares (Indirect, By Seamark Capital)
Footnotes (1)
- F1. This report is being filed to correct the number of shares indirectly held by Mr. Fraser on September 17, 2025 and the presentation of the warrants held on September 17, 2025.
Key Figures
Common shares purchased: 16,389 shares at $0.45
New warrant acquired: 12,292 underlying shares, $0.75 exercise
Direct common shares after transaction: 566,393 shares
+4 more
7 metrics
Common shares purchased
16,389 shares at $0.45
Open-market purchase on September 17, 2025
New warrant acquired
12,292 underlying shares, $0.75 exercise
Derivative purchase on September 17, 2025; expires 2030
Direct common shares after transaction
566,393 shares
Direct ownership following September 17, 2025 trades
Indirect common shares
287,769 shares
Indirectly held via Seamark Capital as of September 17, 2025
Large warrant position 1
900,633 shares at $0.35
Warrant expiring March 5, 2031
Large warrant position 2
68,627 shares at $2.25
Warrant expiring July 9, 2027
Net buy shares equivalent
28,681 shares
Net of reported buy/sell activity in transaction summary
Key Terms
Warrant (Right to Buy), open-market purchase, indirectly held, exercise price, +1 more
5 terms
Warrant (Right to Buy) financial
"security_title: "Warrant (Right to Buy)" with underlying common stock details"
open-market purchase financial
"transaction_action: "open-market purchase" for code P transactions"
An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.
indirectly held financial
"correct the number of shares indirectly held by Mr. Fraser"
exercise price financial
"conversion_or_exercise_price fields such as "0.3500" and "2.2500""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
Form 4/A regulatory
"amended Form 4 ownership report context in the insider filing data"
Form 4/A is an amended filing that corrects or updates an earlier Form 4, the mandatory report that insiders (like company executives, directors, or large shareholders) must file when their ownership stakes change. Think of it as an edited receipt showing who bought or sold stock and when; investors use it to track insider confidence, detect potential conflicts, and spot trading patterns that might signal future company prospects.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does the latest Form 4/A for Aspira Women's Health (AWHL) show?
The Form 4/A shows that director Fraser John D corrected prior ownership details and reported new open-market purchases. He bought 16,389 common shares at $0.45 and a warrant covering 12,292 shares with a $0.75 exercise price on September 17, 2025.
Was the Aspira Women's Health (AWHL) Form 4/A mainly a correction?
Yes. A footnote states the report corrects the indirectly held share count for Fraser on September 17, 2025 and the presentation of his warrants on that date. It updates, rather than newly creating, his previously reported ownership information.
Did Fraser John D buy or sell Aspira Women's Health (AWHL) stock in this Form 4/A?
The filing reports net buying activity. He made open-market purchases of 16,389 common shares at $0.45 and acquired a warrant for 12,292 underlying shares. The transaction summary shows a total net buy of 28,681 shares equivalent.
How significant are the derivative positions reported for Aspira Women's Health (AWHL)?
The filing lists sizable warrant positions: 900,633 underlying shares at $0.35 expiring in 2031 and 68,627 shares at $2.25 expiring in 2027. Together with the new 12,292-share warrant, they represent substantial potential future share acquisitions.